Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-04-11
1997-03-25
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514662, A61K 3113
Patent
active
056145608
ABSTRACT:
Disclosed is a method for reducing non-ischemic NMDA receptor-mediated neuronal damage in a mammal by administering to the mammal a compound of the formula shown in FIG. 1 (or a physiologically-acceptable salt thereof), wherein R.sub.1 includes an amino group, R.sub.2 -R.sub.17 are independently H or a short chain aliphatic group comprising 1-5 carbons, and R.sub.4 and R.sub.10 also may (independently) be a halogen or an acyl group. Also disclosed is a screen for antagonists of NMDA receptor mediated neurotoxicity which have an enhanced prospect for being clinically tolerated and selective against such neurotoxicity.
REFERENCES:
patent: 3328251 (1967-06-01), Smith
patent: 3391142 (1968-07-01), Mills et al.
patent: 3456057 (1969-07-01), Cairns et al.
patent: 4122193 (1978-10-01), Scherm et al.
patent: 4148896 (1979-04-01), Smith et al.
patent: 4273774 (1981-06-01), Scherm
patent: 4351847 (1982-09-01), Griffith et al.
patent: 4806543 (1989-02-01), Choi
patent: 4837218 (1989-06-01), Olney
patent: 5061703 (1991-10-01), Bormann et al.
Merck Index, Rimantadine, No. 8116, p. 1188. (1987).
Merck Index, Amantadine, No. A8, p. APP-2. (1987).
Merk Index, Amantadine, No. 373, p. 55. (1987).
Turski et al., Nature, 349:414-418. (1990).
Kornhuber et al., European Journal of Pharmacology, 166:589-550, 1989.
Borman, European Journal of Pharmacology, 166:591-592, 1989.
Muller, SCRIP 1515, p. 28 (1990).
Tominack and Hayden, Rimantadine and Hydrochloride and Amantadine Hydrochloride, pp. 460-461 (1980).
Braunwald et al., Principles of Internal Med. 11th ed. (N.Y. McGraw Hill 1987) pp. 1392-1396 & 2017-2019.
Hahn et al., Proc. Nat'l Acad. Sci. USA 85:6556-6560 (1988).
Choi et al., Neuron 1:623-634 (1988).
Turski, Arzneim-Forsch./Drug Res. 40(I). NR. 5 (1990).
Meldrum et al., Trends in Parm. Sciences 11:379-387 (1990).
Rothman et al., Trends in Neurosci. 10:299-302 (1987).
Asanaka et al 112CA:232458q 1990.
Merk. Index 10th Ed. #A7, 8116 & 373 1988.
Children's Medical Center Corporation
Criares Theodore J.
LandOfFree
Method of preventing NMDA receptor-mediated neuronal damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preventing NMDA receptor-mediated neuronal damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing NMDA receptor-mediated neuronal damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203938